Detection of aneuploidy in human sperm

Area of Science:

• Human genetics
• Reproductive biology
• Toxicology

Background:

• Direct monitoring of human gametic mutations is challenging.
• Chromosomal aneuploidy is a significant factor in human reproductive failure.
• Existing meiotic studies often require invasive biopsies.

Purpose of the Study:

• To present a novel method for directly monitoring Y chromosomal nondisjunction in male gametes.
• To establish a non-invasive technique for assessing mutagen exposure and reproductive risk.
• To evaluate the potential of this method in clinical drug testing.

Main Methods:

• Quantification of spermatozoa with two fluorescent bodies (YFF) in 1000 sperm.
• Staining dried semen slides with quinacrine dihydrochloride.
• Examination using a fluorescent microscope with dark field illumination.

Main Results:

• The method provides direct quantification of Y chromosomal nondisjunction in ejaculated spermatozoa.
• Increased incidence of YFF sperm observed in patients undergoing antineoplastic therapy and DBCP-exposed workers.
• The technique bypasses the need for biopsies and avoids gametogenic selection bias.

Conclusions:

• This method offers a practical approach to monitor Y chromosomal nondisjunction in men.
• Evaluation prior to conception is recommended for men with a history of mutagen exposure.
• The YFF sperm count can serve as a biomarker for overall autosomal nondisjunction and drug-induced aneuploidy.